.Merck trumps revenues assumptions, brings up sales expectation on tough requirement for best drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Forecasts as Keytruda Purchases Rise BloombergMerck Supply: Pharma Giant Posts Strong Results, Yet Overview Drops Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income and sales expectations amid Keytruda advantage, however provides mixed full-year expectation MarketWatch.